SEARCH

SEARCH BY CITATION

References

  • 1
    Australian Cancer Network Colorectal Cancer Guidelines Revision Committee. Guidelines for the Prevention, Early Detection and Management of Colorectal Cancer. Sydney: The Cancer Council Australia and Australian Cancer Network, 2005.
  • 2
    Young GP, Levin B, Rozen P. Prevention and Early Detection of Colorectal Cancer. London: WB Saunders, 1996; 384.
  • 3
    Wilson JMG, Jungner G. Principles and practice of screening for disease. WHO Public Health Papers No. 34, 1968.
  • 4
    International Agency for Research on Cancer. Use of screening for cervical cancer. In: Cervix Cancer Screening. IARC Handbooks of Cancer Prevention Vol 10. Lyon: IARC Press, 2005; 11762.
  • 5
    Miles A, Cockburn J, Smith RA, Wardle J. A perspective from countries using organized screening programs. Cancer 2004; 101 (Suppl. 5): 120113.
  • 6
    Young GP, Macrae FA, St John DJB. Clinical methods of early detection: basis, use and evaluation. In: YoungGP, LevinB, RozenP, eds. Prevention and Early Detection of Colorectal Cancer. London: WB Saunders, 1996; 24170.
  • 7
    Deeks JJ. Systematic reviews of evaluations of diagnostic and screening tests. BMJ 2001; 323: 15762.
  • 8
    Australian Institute for Health and Welfare. Cancer in Australia—An Overview. Canberra: Australian Institute of Health and Welfare, 2008.
  • 9
    Begg SJ, Vos T, Barker B, Stanley L, Lopez AD. Burden of disease and injury in Australia in the new millennium: measuring health loss from diseases, injuries and risk factors. Med. J. Aust. 2008; 188: 3640.
  • 10
    Bell JC, McCredie M, Coates MS, Armstrong BK. Trends in colorectal cancer incidence and mortality in New South Wales, 1973. Med. J. Aust. 1997; 166: 17881.
  • 11
    Greegor DH. Occult blood testing for detection of asymptomatic colon cancer. Cancer 1971; 28: 1314.
  • 12
    Dent O, Goulston K, St John DJB, Selby W, Young GP. Guidelines for Screening for Colorectal Cancer. Sydney: Australian Gastroenterology Institute, 1991.
  • 13
    Goulston K, St John DJB, Bokey L et al. Guidelines for Early Detection, Screening and Surveillance for Colorectal Cancer. Sydney: Australian Cancer Society, 1994.
  • 14
    Morson BC. Precancerous conditions of the large bowel. Proc. R. Soc. Med. 1971; 64: 95962.
  • 15
    Hamilton SR. Pathology and biology of colorectal cancer. In: YoungGP, RozenP, LevinB, eds. Prevention and Early Detection of Colorectal Cancer. London: WB Saunders, 1996; 322.
  • 16
    Chapuis PH, Goulston KJ, Dent OF, Tait AD. Predictive value of rectal bleeding in screening for rectal and sigmoid polyps. Br. Med. J. (Clin. Res. Ed.) 1985; 290: 15468.
  • 17
    Macrae FA, St. John DJB. Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas. Gastroenterology 1982; 82: 8918.
  • 18
    Pierson RN, Holt PR, Watson RM, Keating RP. Aspirin and gastrointestinal bleeding. Am. J. Med. 1961; 31: 25965.
  • 19
    St John DJB, Young GP, McHutchison JG, Deacon MC, Alexeyeff MA. Comparison of the specificity and sensitivity of Hemoccult and HemoQuant in screening for colorectal neoplasia. Ann. Intern. Med. 1992; 117: 37682.
  • 20
    Ahlquist DA, McGill DB, Fleming JL. Patterns of occult bleeding in asymptomatic colorectal cancer. Cancer 1989; 63: 182630.
  • 21
    Thomas WM, Pye G, Hardcastle JD, Mangham CM. Fecal occult blood screening for colorectal neoplasia: a randomized trial of three days or six days of tests. Br. J. Surg. 1990; 77: 2779.
  • 22
    Young GP, Mandel J, Sung J et al. Guidelines for evaluation of new screening tests: application to colorectal and gastric cancers. Submitted.
  • 23
    Young GP, Allison J. Screening for colorectal cancer. In: YamadaT, AlpersD, KaplowitzN, LaineL, OwyangC, PowellD, eds. Textbook of Gastroenterology, 5th edn. Philadelphia, PA: Lippincott Williams and Wilkins, 2008; 17082.
  • 24
    Sackett DL, Haynes RB, Tugwell P. Clinical Epidemiology. A Basic Science for Clinical Medicine. Boston/Toronto: Little, Brown and Company, 1985; 76126.
  • 25
    Mandel JS, Bond JH, Church TR et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N. Engl. J. Med. 1993; 328: 136571.
  • 26
    Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with fecal-occult-blood test. Lancet 1996; 348: 146771.
  • 27
    Hardcastle JD, Chamberlain JO, Robinson MH et al. Randomised controlled trial of fecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 14727.
  • 28
    Faivre J, Dancourt V, Lejeune C et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology 2004; 126: 167480.
  • 29
    Young GP, Rose IS, St John DJB. Hem in the gut. I: fate of hemoproteins and the absorption of hem. J. Gastroenterol. Hepatol. 1989; 4: 53745.
  • 30
    Rose IS, Young GP, St John DJB, Deacon MC, Blake D. The effect of ingestion of hemoproteins on fecal excretion of hemes and porphyrins. Clin. Chem. 1989; 35: 22906.
  • 31
    Young GP, St John DJB. Fecal occult blood tests: choice, usage and clinical applications. Clin. Biochem. Rev. 1992; 13: 1617.
  • 32
    Young GP, St John DJB. Selecting an occult blood test for use as a screening tool for large bowel cancer. Front. Gastrointest. Res. 1991; 18: 13556.
  • 33
    McDonald CA, Walls RS, Burford Y, Goulston KJ, Yuen AC. Immunochemical detection of fecal occult blood. Aust. N. Z. J. Med. 1984; 14: 10510.
  • 34
    Young GP, St John DJB, Rose IS, Blake D. Hem in the gut. Part II. Fecal excretion of hem and hem-derived porphyrins and their detection. J. Gastroenterol. Hepatol. 1990; 5: 194203.
  • 35
    Lynch NM, McHutchison JG, Young GP, Deacon M, St John DJB, Barraclough D. Gastrointestinal blood loss from a new buffered aspirin (Ostoprin): measurement by radiochromium and HemoQuantTM techniques. Aust. N. Z. J. Med. 1989; 19: 8996.
  • 36
    Mandel JS, Church TR, Bond JH et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N. Engl. J. Med. 2000; 343: 16037.
  • 37
    Mandel JS. Sigmoidoscopy screening probably works, but how well is still unknown. J. Natl. Cancer Inst. 2003; 95: 5713.
  • 38
    Towler BP, Irwig L, Glasziou P et al. Screening for colorectal cancer using the fecal occult blood test, Hemoccult (review). Cochrane Database Syst. Rev. 1998; 2.
  • 39
    Australian Health Technology Advisory Committee. Colorectal Cancer Screening. Canberra: Publications Production Unit, Commonwealth Department of Health and Family Services, 1997.
  • 40
    Young GP, St John DJB, Winawer SJ, Rozen P. Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies. Am. J. Gastroenterol. 2002; 97: 2499507.
  • 41
    St John DJB, Young GP, McHutchison JG, Deacon MC, Alexeyeff MA. Comparison of specificity and sensitivity of Hemoccult and HemoQuant in screening for colorectal neoplasia. Ann. Intern. Med. 1992; 117: 37682.
  • 42
    St John DJB, Young GP, Alexeyeff MA et al. Evaluation of new occult blood tests for detection of colorectal neoplasia. Gastroenterology 1993; 104: 16618.
  • 43
    Smith A, Young GP, Cole SR, Bampton P. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer 2006; 107: 21529.
  • 44
    Young GP, Cole S. Which fecal occult blood test is best for colorectal cancer screening? Nat. Clin. Pract. Gastroenterol. Hepatol. 2009; 6: 1401.
  • 45
    Allison JE, Tekawa IS, Ransom LJ, Adrain AL. A comparison of fecal occult blood tests for colorectal cancer screening. NEJM 1996; 334: 1559.
  • 46
    Young GP. Fecal Immunochemical Tests (FIT) vs Office-Based Guaiac Fecal Occult Blood Test (FOBT). Pract. Gastroenterol. 2004; 28: 4656.
  • 47
    Viiala CH, Olynyk JK. Outcomes after 10 years of a community-based flexible sigmoidoscopy screening program for colorectal carcinoma. Med. J. Aust. 2007; 187: 2747.
  • 48
    Walleser S, Griffiths A, Lord SJ, Howard K, Solomon MJ, Gebski V. What is the value of computered tomography colonography in patients screening positive for fecal occult blood? A systematic review and economic evaluation. Clin. Gastroenterol. Hepatol. 2007; 5: 143946.
  • 49
    Mendelson R, Ramsay D, Edwards J, Forbes G. Virtual colonoscopy: issues in implementation. Australas. Radiol. 2005; 49: 814.
  • 50
    Chin MWS, Mendelson RM, Edwards J, Foster NM. Clinical significance of extracolonic findings in a community screening programme. Am. J. Gastroenterol. 2005; 100: 27716.
    Direct Link:
  • 51
    Scott RG, Edwards JT, Fritschi L, Foster NM, Mendelson RM, Forbes GM. Community-based screening by colonoscopy or computed tomographic colonography in asymptomatic average-risk subjects. Am. J. Gastroenterol. 2004; 99: 114551.
    Direct Link:
  • 52
    Macrae FA, Hill DJ, St John DJ, Ambikapathy A, Garner JF. Predicting colon cancer screening behavior from health beliefs. Prev. Med. 1984; 13: 11526.
  • 53
    Weller DP, Owen N, Hiller JE, Willson K, Wilson D. Colorectal cancer and its prevention: prevalence of beliefs, attitudes, intentions and behaviour. Aust. J. Public Health 1995; 19: 1923.
  • 54
    Young G, Cole S, Roosa N et al. Differences between participants and non-participants in colorectal cancer (CRC) screening. Gastroenterology 2004; 126: S1319.
  • 55
    Duncan A, Wilson C, Cole SR, Mikocka-Walus A, Turnbull D, Young GP. Demographic associations with stage of readiness to screen for colorectal cancer. Health Promot. J. Austr. 2009; 20: 712.
  • 56
    Cole SR, Smith A, Wilson C, Turnbull D, Esterman A, Young GP. An advance notification letter increases participation in colorectal cancer screening. J. Med. Screen. 2007; 14: 735.
  • 57
    Cole S, Smith A, Upton J, Young GP. Is single stool sampling as effective as two stool sampling in fecal immunochemical test based screening for colorectal cancer? Gastroenterology 2007; 132: A314.
  • 58
    Cole SR, Young GP. Participation in fecal occult blood test-based screening for colorectal cancer is reduced by dietary restriction. Med. J. Aust. 2001; 175: 1958.
  • 59
    Cole SR, Young GP, Esterman A, Cadd B, Morcom J. A randomized trial of the impact of new fecal hemoglobin test technologies on population participation in screening for colorectal cancer. J. Med. Screen. 2003; 10: 11722.
  • 60
    Multicentre Australian Colorectal-neoplasia Screening (MACS) Group. A comparison of colorectal neoplasia screening tests: a multicentre community-based study of the impact of consumer choice. Med. J. Aust. 2006; 184: 54650.
  • 61
    Scott RG, Edwards JT, Fritschi L, Foster NM, Mendelson RM, Forbes GM. Community-based screening by colonoscopy or computed tomographic colonography in asymptomatic average-risk subjects. Am. J. Gastroenterol. 2004; 99: 114551.
    Direct Link:
  • 62
    Weller D, Thomas D, Hiller J, Woodward A, Edwards J. Screening for colorectal cancer using an immunochemical test for fecal occult blood: results of the first 2 years of a South Australian programme. Aust. N. Z. J. Surg. 1994; 64: 4649.
  • 63
    Macrae FA, Hill DJ, Dent O, Goulston KJ, St John DJ. Colorectal cancer: knowledge and attitudes of doctors in Victoria. Aust. N. Z. J. Med. 1982; 12: 27883.
  • 64
    Cole SR, Young GP, Byrne D, Guy J, Morcom J. Participation in fecal occult blood test-based screening for colorectal cancer is improved by endorsement by the primary care practitioner. J. Med. Screen. 2002; 9: 14752.
  • 65
    Salkeld S, Young G, Irwig L, Haas M, Glasziou P. Cost-effectiveness analysis of screening by fecal occult blood testing for colorectal cancer in Australia. Aust. J. Public Health 1996; 20: 13843.
  • 66
    O'Leary BA, Olynyk JK, Neville AM, Platell CF. Cost-effectiveness of colorectal cancer screening: comparison of community-based flexible sigmoidoscopy with fecal occult blood testing and colonoscopy. J. Gastroenterol. Hepatol. 2004; 19: 3847.
  • 67
    Monitoring and Evaluation Steering Committee. Australia's Bowel Cancer Screening Pilot and Beyond. Final Evaluation Report. Bowel Cancer Screening Pilot. Aust Government, Department of Health and Ageing. October 2005; Screening Monograph No. 6/2005.